의학 연구자들은 수십 년째 소변으로 건강을 진단하려 해왔다. 혈당, 단백질, 특정 호르몬 — 소변 속에는 우리 몸의 대사 활동을 알려주는 수많은 단서가 담겨 있다. 그런데 최첨단 질량분석법을 이용하자, 지금껏 아무도 보고하지 않은 화합물 23종이 인간의 소변에서 한꺼번에 발견됐다.
미국 국립표준기술연구소(NIST) 생체분자측정부 연구팀이 *Analytical and Bioanalytical Chemistry*에 발표한 이 연구는 NIST가 보유한 6종의 인간 소변 표준 참조 물질을 다중 에너지 액체 크로마토그래피-탠덤 질량분석법(LC-MS/MS)으로 재분석했다. 새로운 분석 전략은 세 단계로 구성됐다: ① 낮은 충돌 에너지에서 당 특이 단편 이온과 중성 손실 검증, ② 높은 충돌 에너지에서 비당 성분(NSC) 단편 추출 및 라이브러리 매칭, ③ MS1 기능 재구성을 통한 질량·농도·이온 관계 검증.
이 방법으로 기존에 보고되지 않았던 당-소분자 결합체 23종이 새로 확인됐다. 구체적으로는 N-아세틸글루코사민(GlcNAc) 결합 8종, N-아세틸갈락토사민(GalNAc) 결합 12종, N-아세틸뉴라민산(NeuAc) 결합 3종이다. 특히 GalNAc와 NeuAc를 포함한 결합체는 이 분석에서 처음 발견된 것으로, 인체 소형 분자 결합에 관여하는 당의 종류가 기존 예상보다 더 다양함을 보여준다.
발견된 결합체 23개 중 15개에는 글루쿠론산(GlcA)이 포함돼 있었고, 그 중 14개에서 GlcA가 추가 당 분자와 비당 성분을 연결하는 '교량' 역할을 했다. 비당 성분에는 체내 내인성 화합물과 외래 물질(의약품·환경화합물 등) 유래 성분이 모두 포함됐다.
6개 소변 시료 간의 반정량 분석 결과, 발견된 화합물들의 농도는 시료마다 큰 차이를 보였다. 이는 동일 화합물이라도 개인에 따라 대사 경로 활성도가 다를 수 있음을 시사한다. 만약 특정 결합체가 질환 상태에서 특이적으로 증가하거나 감소한다면, 미래에 소변 기반 바이오마커로 활용될 잠재력이 있다.
이번 연구의 직접적인 임상 함의는 아직 제한적이다. 이 화합물들이 인체 건강에 어떤 영향을 미치는지, 특정 질환과 연관되는지는 후속 연구가 필요하다. 그러나 인체 대사체학의 미지 영역을 좁혔다는 점에서 기초과학적 의의가 크다.
📖 *Identification of novel sugar-small-molecule conjugates in human urine based on multi-energy LC-MS/MS analysis (분석화학 연구, NIST 소변 참조 물질 6종)* |
논문 원문
※ 이 기사는 의학 논문을 바탕으로 작성되었습니다. 개인 건강 상태에 따라 다를 수 있으니 전문의와 상담하세요.
Every day, your body processes thousands of compounds — nutrients, medications, environmental chemicals, and the metabolic byproducts of its own biological machinery. Many of these molecules get chemically tagged with sugar groups before being excreted in urine, a process called conjugation that helps the body neutralize and dispose of substances it can't use. Scientists have known about this process for decades, but the full picture of what actually ends up in human urine has remained stubbornly incomplete.
Now, a team at the National Institute of Standards and Technology (NIST) has pushed that boundary further. Using a new multi-energy mass spectrometry strategy applied to six well-characterized human urine reference materials, they identified 23 previously unreported sugar-small-molecule conjugates — compounds that no published study had ever described.
The research, published in *Analytical and Bioanalytical Chemistry*, demonstrates that the metabolic chemistry occurring inside the human body is considerably richer than current databases suggest.
The Analytical Challenge
Sugar-conjugated metabolites are notoriously difficult to identify because their structural complexity makes standard spectral library matching unreliable. The sugar portion of the molecule dominates the mass spectrum at typical collision energies, masking the chemical identity of the non-sugar component attached to it.
The NIST team developed a three-step framework to overcome this: first, confirming the sugar identity using diagnostic fragment ions at low collision energies; second, applying higher collision energies to generate fragments from the non-sugar component (NSC) and match those against spectral libraries; and third, using MS1-level feature reconstruction to validate the compound's mass, retention time, abundance, and relationships with other ions. This layered approach could reliably separate what the sugar is from what it's attached to.
What They Found
Applying this strategy to six NIST Standard Reference Materials (urine from multiple donors), the team discovered 23 novel conjugates: 8 containing N-acetylglucosamine (GlcNAc), 12 containing N-acetylgalactosamine (GalNAc), and 3 containing N-acetylneuraminic acid (NeuAc, also known as sialic acid).
The detection of GalNAc and NeuAc in these small-molecule conjugates is particularly noteworthy — prior to this work, these sugars were not known to participate in small-molecule biotransformation. Their involvement suggests that the enzymatic machinery responsible for sugar conjugation is more versatile than appreciated.
Of the 23 conjugates, 15 contained glucuronic acid (GlcA) — a well-known conjugation sugar. But in 14 of those cases, GlcA served as a structural bridge linking an additional sugar to the non-sugar component, creating more complex molecular architectures than simple single-sugar attachments.
The non-sugar components spanned both endogenous compounds (produced by the body itself) and xenobiotics — substances derived from drugs, dietary components, or environmental chemicals. This dual origin suggests that the newly discovered conjugates reflect both normal metabolism and the body's handling of external compounds.
Inter-Individual Variability as a Clue
Semi-quantitative analysis across the six urine samples revealed something clinically suggestive: while the detection of conjugates was highly consistent (validating the method's reliability), the concentrations varied considerably between samples. This pronounced inter-individual variability hints that these conjugates might one day serve as biomarkers — reflecting differences in metabolic enzyme activity, drug metabolism efficiency, or even disease states.
Whether any of these 23 compounds correlate with specific health conditions, medications, or environmental exposures remains entirely unknown at this stage. The study identifies and characterizes the compounds; establishing their biological significance is the work of future research.
Why This Matters for Medicine
The human metabolome — the complete set of small molecules in the body — is far from fully mapped. An estimated 40–60% of metabolites detected in human biofluids remain unannotated. Each newly identified compound expands the reference libraries that clinical and research laboratories use to interpret metabolomics data, potentially enabling more accurate disease diagnosis, drug monitoring, and toxicology assessments in the future.
For now, this work is foundational science. But it's a reminder that the urine you discard daily contains molecular information about your body's inner workings that scientists are still learning to read.
📖 *Identification of novel sugar-small-molecule conjugates in human urine based on multi-energy LC-MS/MS analysis (Analytical chemistry study, 6 NIST urine reference materials)* |
Source
※ This article is based on a published medical study. Individual health circumstances vary — consult your physician before making any changes to your care.
